The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 11, 2020

Filed:

May. 30, 2018
Applicant:

Nantbio, Inc., Culver City, CA (US);

Inventors:

Chunlin Tao, Newport Coast, CA (US);

Qinwei Wang, Alhambra, CA (US);

Sharif Asad, Lake Forest, CA (US);

Paul Weingarten, Anaheim, CA (US);

Sherry Ci, San Marino, CA (US);

Assignee:

NANTBIO, INC., Culver City, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/14 (2006.01); A61P 35/00 (2006.01); A61P 29/00 (2006.01); A61P 25/28 (2006.01); A61K 31/4155 (2006.01);
U.S. Cl.
CPC ...
C07D 403/14 (2013.01); A61K 31/4155 (2013.01); A61P 25/28 (2018.01); A61P 29/00 (2018.01); A61P 35/00 (2018.01);
Abstract

The present invention relates to the use of substituted pyrimidine derivatives to modulate tropomyosin-related kinase (Trk) family protein kinase, and the use of the substituted pyrimidine derivatives for the treatment of pain, inflammation, cancer, restenosis, atherosclerosis, psoriasis, thrombosis, a disease, disorder, injury, or malfunction relating to dysmyelination or demyelination or a disease or disorder associated with abnormal activities of nerve growth factor (NGF) receptor TrkA. The present invention also provides compounds of the formula: as defined herein.


Find Patent Forward Citations

Loading…